Oleoylethanolamide (OEA): A Key PPAR-α Agonist for Pharmaceutical Applications
Discover the role of Oleoylethanolamide (OEA) in metabolic health. As a trusted manufacturer and supplier in China, we offer high-purity OEA for your research and pharmaceutical formulation needs, supporting the development of treatments for obesity and arteriosclerosis.
Get a Quote & SampleHigh Purity Oleoylethanolamide for Pharmaceutical Innovation
Oleoylethanolamide (OEA)
As a leading Oleoylethanolamide supplier in China, we provide N-(2-Hydroxyethyl)oleamide with exceptional purity (≥98%). Our product, CAS 111-58-0, is a vital ingredient for pharmaceutical applications targeting obesity and arteriosclerosis. Explore our competitive OEA price and secure a reliable source for your formulations.
- High-Purity Oleoylethanolamide Manufacturer: Ensuring quality for your pharmaceutical needs.
- CAS 111-58-0 Availability: Buy Oleoylethanolamide for advanced research.
- PPAR-α Agonist Properties: Essential for obesity and arteriosclerosis treatments.
- Reliable OEA Supplier in China: Secure your supply chain with consistent quality.
Advantages of Sourcing Oleoylethanolamide from Us
Exceptional Purity Guarantee
We are a dedicated Oleoylethanolamide manufacturer committed to supplying N-(2-Hydroxyethyl)oleamide with purity levels of ≥98%. This ensures reliable and reproducible results in your pharmaceutical research, making us a trusted OEA supplier.
Therapeutic Potential Support
Leverage the power of Oleoylethanolamide (OEA) as a high-affinity endogenous PPAR-α agonist. Our product is crucial for developing treatments for obesity and arteriosclerosis, supporting innovation in the pharmaceutical sector.
Competitive Pricing and Availability
As a direct manufacturer and supplier in China, we offer competitive Oleoylethanolamide prices. Secure your purchase of OEA with us for consistent supply and excellent value for your development projects.
Key Applications of Oleoylethanolamide
Obesity Management Treatments
Explore the use of our high-purity Oleoylethanolamide (OEA) in formulating novel treatments for obesity, leveraging its role as a PPAR-α agonist.
Arteriosclerosis Therapies
Utilize CAS 111-58-0 in research and development for arteriosclerosis, where OEA demonstrates significant therapeutic promise.
Pharmaceutical Research and Development
As a reliable Oleoylethanolamide supplier, we cater to R&D needs, providing essential intermediates for drug discovery and formulation.
Metabolic Health Enhancements
Investigate the broader applications of OEA in improving metabolic health, supported by our commitment to quality and supply consistency.